XEROX CORPORATION for XEROX CORPORATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Foreign market compliance monitoring
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELE L CAHN | — |
| STEPHEN SCHAEFER | — |
Health Issues HCR
Affordable Care Act -- Section 4980I -- 40% Excise tax on Health Benefits; Implementation of excise tax and application to large employers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELE L CAHN | — |
| EDWIN EGEE | — |
Financial Institutions/Investments/Securities FIN
H.R. 5983 - Financial CHOICE Act of 2016; Dodd-Frank Repeal and Replacement
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELE L CAHN | — |
| EDWIN EGEE | — |
Taxation/Internal Revenue Code TAX
All provisions related to corporate tax reform, corporate alternative minimum tax credits and R&D extension.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELE L CAHN | — |
| ALEC ROGERS | — |
Retirement RET
H.R.4955, S. 3240 - Pension and Budget Integrity Act; Legislation seeks to prohibit Congress from using PBGC premium increases as a way to balance federal budget S. 3471 - Retirement Enhancement and Savings Act of 2016; Bipartisan pension reform legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELE L CAHN | — |
| EDWIN EGEE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.